3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 4
1
Phase 2
1
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Uterine Diseases
1
Pain
1
Leiomyoma
1
Dysmenorrhea
1
Interventions
Dexamethasone
12
Bevacizumab
9
Saline Solution
8
Bupivacaine
8
Tobacco Use Cessation Devices
7
Specimen Handling
7
Nivolumab
7
Magnetic Resonance Spectroscopy
7
Rituximab
6
Prednisone
6
Letrozole
6
Lenalidomide
6
Fluorouracil
6
Cisplatin
6
Carboplatin
6
pembrolizumab
5
Sodium Chloride
5
Ropivacaine
5
Human Papillomavirus Recombinant Vaccine nonavalent
5
Trastuzumab
4
Tamoxifen
4
Standard of Care
4
Propofol
4
Paclitaxel
4
Immune Checkpoint Inhibitors
4
Esomeprazole
4
Enoxaparin
4
Doxorubicin
4
Bortezomib
4
Bismuth
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Naproxen
×
1 year
×
Clear all
NCT04145518
2025-12-12
MCUP
Endeavor Health
Phase 4
Completed
183 enrolled